Back to BlackRock, Inc. BlackRock, Inc.

QNCXQNCX
6 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in QUINCE THERAPEUTICS INC

BlackRock, Inc. holds 473,259 shares of QNCX (QUINCE THERAPEUTICS INC), worth $47,989 as of 2026-Q1. The position was increased (+0.3% shares).

Current Value

$47,989

Current Shares

473,259

Total Value Change

-$789,272

Total Shares Change

+25,526

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
473,259
+0.3%
$47,9890.0%$0.10
14
2025-Q4
Increased
471,989
+36.6%
$1.6M0.0%$3.26
23
2025-Q3
Increased
345,461
+2.9%
$563,1010.0%$1.61
17
2025-Q2
Decreased
335,738
-2.8%
$553,9680.0%$1.55
0
2025-Q1
Decreased
345,448
-22.9%
$459,4460.0%$1.35
0
2024-Q4
New
447,733
-
$837,2610.0%$1.85
38

Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used